7/8/2025CStone and Istituto Gentili Forge Partnership for Sugemalimab in Weste...

7/8/2025China Hospitals Prioritize Local Innovation, Digital Health, and Profi...

7/8/2025Fosun USA and MAP International Partner to Expand Medicine Access

7/8/2025Hansoh Launches Phase 1 Combo Trial of HS‑20093 ADC in ES‑SCLC

7/8/2025DualityBio Launches Phase 3 Trial of HER2 ADC DB‑1303 in China for Re...

7/8/2025XellSmart Completes New Financing, Secures FDA Clearance for iPSC-Deri...

7/8/2025China's NMPA Reopens Public Consultation on Revised Conditional Approv...

7/8/2025NMPA Releases 93rd Batch of Reference Formulations for Generic Drug Ev...

7/8/2025Novo Nordisk Commits CNY 800M to Expand Quality Lab at Tianjin Manufac...

7/8/2025U.S. Lawmakers Raise Fresh Alarm Over GenScript's China Links

7/8/2025ArkBio's ADHD Drug Azstarys Granted Priority Review in China

7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...

7/4/2025Shaanxi Micot Secures 100M CNY in Series D Financing

7/4/2025Brii Biosciences Taps Joincare Pharma to Drive BRII‑693 in Greater Ch...

7/4/2025Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...

7/4/2025AstraZeneca Eyes $15B Deal for Summit's Chinese-Developed Lung Cancer ...

7/4/2025CDE Seeks Comment on Revised eCTD Technical Documents and Mapping Tabl...

7/4/2025CDE Solicits Comments on the 95th Batch of Reference Formulations for ...

7/3/2025CStone Expands Pipeline with Novel BsAb Targeting Autoimmune and Infla...

7/3/2025Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Rivals in EGFR Exo...

7/3/2025Akeso Launches Clinical Trials for First Bispecific ADC

7/3/2025Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Million in IPO

7/3/2025Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...

7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders

7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...

7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...

7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...

7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

Page:27/802 Total number of articles:24041: [First][<<] [25] [26] [27] [28] [29] [>>] [End]